Pharma major GlaxoSmithKline Pharmaceuticals (GSK) has launched ‘Trust in Science’ initiative in partnership with the Regional Centre for Biotechnology (RCB), to develop PhD courses in biostatistics and bioinformatics. A Vaidheesh, Vice President, South Asia and Managing Director, GSK tells more to Akanki Sharma
Kindly share a brief about the ‘Trust in Science’ programme. What does it offer and who are its beneficiaries?
Globally, GSK Pharmaceutical’s ‘Trust in Science’ initiative is a novel public-private partnership model to build R&D capacity for development and discovery in science. The pillars of this initiative are scientific excellence, trust and talent development in line with GSK’s science, technology and cultural values.
In India, we have launched the ‘Trust in Science’ initiative in partnership with the Regional Centre for Biotechnology (RCB), one of India’s academic research institutions to develop PhD courses in biostatistics and bioinformatics. The initiative covers scholarship costs and provides expert guidance to 12 students, so that they can complete their doctoral degrees. Any student with a master’s degree in biostatistics and bioinformatics is eligible to apply for this programme.
What prompted you to initiate a doctoral programme for bioinformatics and biostatistics only? How do you think it is going to benefit the pharma sector in India?
Our industry is generating huge amounts of biological and genomic data. This means we are dealing with massive data sets which were unimaginable some 20 years ago. Now comes the challenge of mining this data for insights and trends which can be extrapolated in a way that leads us to think and plan our future more strategically. Both bioinformatics and biostatistics offer immense promise here. Both the fields can drive the investigation and processing of large sets of biological information in a short period of time. This is of great value to a country like ours, with large sample sizes and varying factors that influence disease and healthcare delivery.
This story is from the August 01-15, 2019 edition of Express Pharma.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the August 01-15, 2019 edition of Express Pharma.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation
